Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Moderate to severe melasma of the face Age: Adult |
Dose: Topical/Cutaneous – Thin layer Frequency: once daily Duration: should not exceed 8 weeks Note: Apply onto the hyperpigmented areas of melasma 30 minutes before bedtime. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- Wash face gently before use
- Apply thin layer to dark spots and slightly beyond
Side Effect
- Erythema (41-45%)
- Desquamation (36-40%)
- Burning (16-20%)
- Dryness (11-15%)
- Pruritis (11-15%)
- Acne (5%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Medicated or abrasive soaps & cleansers, Soaps & cosmetics with drying effects, Products with high conc of alcohol & astringent, Other irritants or keratolytic drugs
|
Interaction
|
|
Medications with photosensitizing effects
|
Interaction
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool & dry place, protected from light. Do not freeze. Keep out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.